(19)
(11) EP 1 558 341 A2

(12)

(88) Date of publication A3:
30.09.2004

(43) Date of publication:
03.08.2005 Bulletin 2005/31

(21) Application number: 03783155.9

(22) Date of filing: 03.11.2003
(51) International Patent Classification (IPC)7A61P 31/00, A61K 31/55, A61K 31/495, A61K 31/50, A61K 31/535, A61K 31/44, A61K 31/41, A61K 31/425, A61K 31/415, A61K 31/42, C07D 235/00
(86) International application number:
PCT/US2003/035205
(87) International publication number:
WO 2004/041209 (21.05.2004 Gazette 2004/21)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 01.11.2002 US 423319 P
13.11.2002 US 425916 P

(71) Applicant: Paratek Pharmaceuticals, Inc.
Boston, MA 02111 (US)

(72) Inventors:
  • LEVY, Stuart, B.
    Boston, MA 02116 (US)
  • ALEKSHUN, Michael, N.
    Wakefield, MA 01880 (US)
  • PODLOGAR, Brent, L.
    Hamden, CT 06518 (US)
  • OHEMENG, Kwasi
    Norwood, MA 02062 (US)
  • VERMA, Atul, K.
    Mansfield, MA 02048 (US)
  • WARCHOL, Tadeusz
    Northborough, MA 01532 (US)
  • BHATIA, Beena
    Mansfield, MA 02048 (US)
  • BOWSER, Todd
    Charlton, MA 01507 (US)
  • GRIER, Mark
    Cambridge, MA 02141 (US)

(74) Representative: Nash, David Allan 
HASELTINE LAKE,Redcliff Quay120 Redcliff Street
Bristol BS1 6HU
Bristol BS1 6HU (GB)

   


(54) TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF